Introduction {#S1}
============

*Sarcina ventriculi* is a Gram-positive, obligate anaerobic coccus, present in the soil, with a characteristic tetrad or octet morphology. Only 22 cases of human infections by this microorganism, including 7 children, have been described in literature to date. The majority of cases presented with abdominal pain, nausea, vomiting, and delayed gastric emptying. In a few cases, infection was associated with life-threatening complications, like emphysematous gastritis and gastric perforation. Here, we report two children with a *S. ventriculi* infection in whom the diagnosis could be made on typical histological findings in the mucosal biopsies. The first child presented with hematemesis due to ulcerative esophagitis and gastritis, the second child with a history of esophageal stricture had ulcerative gastritis. In both children, symptoms resolved completely following targeted antibiotics.

Case Presentation {#S2}
=================

The first patient was a 12-year old girl with a history of psychomotor retardation and refractory epilepsy based on West syndrome. Furthermore, she was diagnosed twice with an episode of *Helicobacter pylori*-associated gastritis, successfully eradicated with triple therapy on both occasions. Percutaneous endoscopic gastrostomy (PEG) was performed early in life for long-term administration of enteral nutrition. She was admitted to the hospital because of mild dehydration due to intractable vomiting since 3 days, possibly including blood. Aspiration of stomach content *via* the PEG tube revealed retention of a large amount of brownish fluid. On physical examination, the patient was tachycardic (110 beats/min), with normal blood pressure and oxygen saturation. Palpation of the abdomen was not painful, and no other physical signs were present, besides her pre-existent neurological impairment. Laboratory investigation showed normal hemoglobin concentration (9.5 mmol/l), mean cellular volume 94 fl, normal platelet count, and normal infection and clotting parameters. At admission, she was already on omeprazole (20 mg/day), next to phenobarbital and gabapentin as antiepileptic treatment. Differential diagnosis included Mallory--Weiss syndrome, viral gastro-enteritis, esophagitis, recurrence of *H. pylori*-associated ulcer/gastritis, and bleeding from esophageal varices. Portal hypertension was excluded by abdominal ultrasound and *H. pylori* antigen stool test was negative. Omeprazole was increased to 40 mg/day. No hematemesis was observed during the 3 days of admission, and therefore, esophagogastroduodenoscopy was not performed. After 1 month, the patient was readmitted because of status epilepticus, possibly due to insufficient intake of antiepileptic medication linked to a gradual increase of vomiting. Convulsions were adequately treated with intravenously administered midazolam. Three days prior to this second admission, the mother of the patient had aspirated large amounts of bloody retention from the stomach, but the hemoglobin level was not decreased compared to the previous admission. One day following this second admission, the patient had an episode of hematemesis, and therefore, a esophagogastroduodenoscopy was performed under general anesthesia. A timeline displaying the course of clinical symptoms is depicted in Figure [1](#F1){ref-type="fig"}.

![Timeline displaying the course of clinical symptoms of case 1.](fmed-04-00145-g001){#F1}

Endoscopy showed a severe, erosive esophagitis of the distal 15 cm of the esophagus (Figure [2](#F2){ref-type="fig"}). Furthermore, a multifocal hemorrhagic antral and corporal gastritis was observed (Figure [3](#F3){ref-type="fig"}), next to two circular antral ulcers with a diameter of 5 mm. Notably, a large amount of stomach retention was observed, indicative for delayed gastric emptying. Histological examination of esophageal and gastric biopsies showed severe ulcerative esophagitis and gastritis, next to the presence of bacteria in the gastric and esophageal mucous surface. The bacteria were arranged in tetrad and octet groups, compatible with *S. ventriculi* (Figures [4](#F4){ref-type="fig"}A,B). *H. pylori* was not observed.
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![*Sarcina ventriculi* in esophageal biopsies. These microorganisms appear to be arranged in tetrads \[**(A)** 200×\], but on higher magnification appear to be arranged in cubes composed of eight individual spheres \[**(B)** 400×\].](fmed-04-00145-g004){#F4}

Culture of the mucosal biopsies was negative, including culture for *H. pylori*. Subsequently, we applied a molecular microbiota profiling technique, called IS-pro, which confirmed the presence of *S. ventriculi*. Patient was treated with ciprofloxacin and metronidazole for 10 days and the symptoms of bloody stomach retention and hematemesis resolved completely within several days. Control esophagogastroduodenoscopy performed after 6 weeks showed complete healing of the gastric and esopgaheal mucosa. In the mucosal biopies, *S. ventriculi* could no longer be detected. Duration of follow-up was 12 months, during which period no recurrence of symptoms was reported.

Case 2 {#S2-1}
------

The second patient was a 15-year-old Caucasian girl with a history of severe neurological impairment and epilepsy due to intracranial hemorrhage from a cerebral arteriovenous malformation at 8 years of age. She was prescribed Clobazam and Keppra as antiepileptic agents and had a PEG tube for administration of enteral nutrition. She presented with respiratory failure due to an aspiration pneumonia, for which mechanical ventilation was required. Because of the inability to insert a nasogastric tube during admission, a single-contrast study of the esophagus was performed, which showed a mid-esophageal stricture over a length of 10 cm. An upper endoscopy was performed which confirmed the presence of a mid-esophageal pinpoint stenosis. Endoscopy was also performed through the gastrocutaneous fistula for retrograde inspection of the distal esophagus. Here, we observed a diffuse erosive gastritis and a large gastric circular ulcer with a diameter of 10 mm at the gastro-esophageal junction with no signs of esophagitis (Figure [5](#F5){ref-type="fig"}). Furthermore, a significant amount of stomach retention was seen, despite 12 h of fasting, suggestive of delayed gastric emptying. Histological examination of gastric biopsies showed active gastritis with the presence of microorganisms arranged in tetrads, characteristic of *S. ventriculi*, which was confirmed by the IS-pro technique. *H. pylori* and *Giardia lamblia* were not detected. The patient was prescribed ciprofloxacin and metronidazole for 10 days, next to omeprazole (40 mg/day). At endoscopic follow-up 6 weeks following antibiotics, the gastritis and gastric ulcer were healed completely and *S. ventriculi* could no longer be detected from the biopsies. Endoscopic dilatation of the esophageal stricture was successfully performed using Savary-Gilliard bougies. A timeline with the course of clinical symptoms is depicted in Figure [6](#F6){ref-type="fig"}. During follow-up period of 8 months, no recurrence was reported.
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![Timeline displaying the course of clinical symptoms of case 2.](fmed-04-00145-g006){#F6}

Discussion {#S3}
==========

In 1842, John Goodsir was the first to describe the presence of *Sarcina* microorganisms in the stomach of a patient presenting with abdominal pain, bloating, and vomiting ([@B1]). The pathogenic role of *S. ventriculi* has been well established in the veterinary literature, including description of several fatal cases, called "abomasal bloat," in livestock ([@B2], [@B3]). Its pathogenicity in humans has been questioned until recent years, since only few symptomatic infections with *Sarcina* organisms in humans have been described, only 22 cases in literature so far ([@B4]--[@B18]), while *S. ventriculi* has also been detected in asymptomatic subjects ([@B19], [@B20]). Sites of infections described thus far include the stomach (85%), esophagus (10%), and duodenum (5%) ([@B21]). Presenting symptoms in patients with *S. ventriculi* commonly include abdominal pain, nausea, vomiting, and, as in our case, delayed gastric emptying ([@B8], [@B9]). Severe complications like emphysematous gastritis and gastric perforation have also been reported ([@B4], [@B5]). It has been suggested that impaired gastric emptying could be a risk factor for the growth of *S. ventriculi* ([@B8], [@B9]). The majority of affected patients do not have mucosal injury on endoscopy, but increasing evidence suggests that *S. ventriculi* is associated with gastric ulcers, with an incidence of over 30% in *Sarcina* infections, and subsequently with an increased risk for emphysematous gastritis and gastric perforation ([@B7], [@B21]). Only seven children with symptomatic *S. ventriculi* infection have been described in literature so far ([@B5]--[@B7], [@B11], [@B12], [@B22]), two of them presenting with (partial) gastric necrosis. Notably, all described children had a concurrent gastrointestinal disease, including *H. pylori* gastritis (*n* = 2), infection with *G. lamblia* or *Candida* spp., history of esophageal atresia and post gastric pull through with anastomotic narrowing, and celiac disease. Our first case had no (recognized) gastrointestinal diagnosis, both cases had a PEG tube placement for administration of enteral nutrition. An association between a PEG tube and *S. ventriculi* infection has not been described previously. In three of seven affected children described in literature, endoscopy revealed the presence of distal esophagitis and none of them had hematemesis as presenting symptom ([@B7], [@B8]). Cultivation of *S. ventriculi* is complicated by its complex nutritional requirements, but diagnosis can usually be made based on typical morphological features ([@B11]). Diagnosis can be confirmed by means of molecular techniques like sequencing or, as in our case, by IS-pro, a eubacterial DNA-based molecular detection technique ([@B23]). IS-pro is based on identification of species-specific length polymorphisms of the interspacer region and phylum-specific sequence polymorphisms of 16S rDNA. Treatment of *S. ventriculi* usually consists of proton pump inhibitors and antibiotics, with metronidazole and ciprofloxacin as most frequently prescribed agents ([@B3], [@B19]). In our first case description, the patient was already on proton pump inhibitors prior to onset of complaints, and she recovered both clinically and endoscopically following administration of ciprofloxacin and metronidazole.

The association between *S. ventriculi* infections and esophageal strictures, as described in case 2, has already been described over a century ago ([@B22]). In an intriguing experiment by Beijerinck et al. performed in 1911 under strict anaerobic conditions to prove the similarity between *S. ventriculi* isolated from garden soil and from stomach contents, the researchers used from stomach contents from patients with esophageal stenosis and suffering from *S. ventriculi* infection ([@B22]). This association has not been described in subsequent reports on human *S. ventriculi* infections. In case 2, *S. ventriculi* was detected in mucosal biopsies from the stomach, but not from the esophagus. We, therefore, believe that *S. ventriculi* infection is more likely to be a consequence rather than a cause of esophageal strictures; severe stenosis may create optimal anaerobic conditions for *S. ventriculi* to grow.

In conclusion, *S. ventriculi* infection is a rare cause of ulcerative gastritis and esophagitis in children, with delayed gastric emptying as possible predisposing factor. Diagnosis is usually established by typical histological findings and can be confirmed by means of molecular detection techniques. Since infection may lead to life-threatening complications, it should be treated promptly with proton pump inhibitor and antibiotics.
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